Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

Jabil acquires Pharmaceutics International, Inc

suites for oral products (e.g., soft gels), an aseptic facility for injectables (e.g., vials, syringes, and cartridges), a formulation development center, and analytical and microbiology laboratories. This expertise will add a comprehensive...

Zafrens expands its investor syndicate to scale its revolutionary drug discovery platform

Zafrens, a pioneering biotech company transforming drug discovery, welcomes imec.xpand to its Series A syndicate, bringing the total capital raised to USD 31 million. imec.xpand is joined by existing investors Prime Movers Lab, Kofa Healthcare,...

Harbour BioMed receives NMPA IND clearance for HBM9378/SKB378 in treating chronic obstructive pulmonary disease

monoclonal antibody targeting TSLP, generated from the two heavy chains and two light chains (H2L2) Harbour Mice® platform. It inhibits the TSLP-mediated signaling pathway by blocking the interaction between TSLP and its receptor, which is a...

Avanzanite Bioscience has appointed a new Chief Financial Officer

In doing so, we are redefining the future of orphan medicine commercialization and distribution across Europe. For more information, visit www.avanzanite.com.

HOOKIPA Pharma announces the completion of enrollment in its Phase 1b clinical trial evaluating HB-500 for the treatment of HIV

acid sequence allowing for coverage of >80% of circulating HIV-1 viral variants. About HIV: HIV is one of the world’s most formidable public health challenges. It is estimated there are more than 38 million people living with HIV worldwide. The...

Datar Cancer Genetics will provide groundbreaking video-enhanced results of in-vitro chemotherapy effectiveness tests for cancer patients

standard-of-care (SoC) and off-label drugs which are critical for treatment of drug-resistant cancers. DCG's advanced platform uses human-supervised AI to analyze high-resolution, real-time videos of tumor cells exposed to chemotherapy drugs. These...

Dipal Doshi has been elected to Azenta's Board of Directors

our industry-leading brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey. For more information, please visit www.azenta.com.

The merger with NLS Pharmaceutics was approved by Kadimastem shareholders

led by an experienced management team with a track record of developing and commercializing product candidates. For more information, please visit www.nlspharma.com. About Kadimastem: Kadimastem is a clinical stage cell therapy company, developing...

Redefining Pharmaceutical Market Analytics and Insights: PharmaScroll

& Dashboarding, BD&L Support, KOL Profiling, Sales Force Analytics, and Predictive Analytics to help clients make informed and strategic decisions. Social Media Analytics - Social listening through patient and physician forums for Performance &...

To facilitate SPR integration into high-throughput biologics discovery workflows, Nicoya launches the Alto Automation Suite

launch of the Alto Automation Suite™ for its flagship Alto™ Digital SPR™ system. This makes Alto the world’s first SPR platform that is fully compatible with standard lab automation, enabling thousands of samples per week to be run without human...

Supporting the lab of the future, MilliporeSigma partners with Opentrons Labworks, Inc

assay kits on a custom Opentrons Flex® workstation. Scientists and engineers will collaborate to develop and verify platform workflows utilizing the broad offering of automation-enabled assays from the Life Science business of Merck KGaA,...

Beacon Therapeutics has been granted FDA Regenerative Medicine Advanced Therapy (RMAT) designation for laru-zova (AGTC-501)

Syncona Limited, Forbion, Oxford Science Enterprises, TCGX, Advent Life Sciences and additional investors. Find more information please visit, www.beacontx.com.

Lutris Pharma secures $30 million in financing to advance the development of a biopharmaceutical aimed at improving the effectiveness of anti-cancer drugs

leading to substantial discontinuation of patients' treatment in less than three months due to intolerable acneiform rashes. LUT014, a novel B-Raf inhibitor, is used for patients who develop dose-limiting rashes, potentially allowing them to...

Cellipont Bioservices and Secretome Therapeutics partner for cGMP manufacturing of the Master Cell Bank for their lead asset, STM-01

for cell and gene therapies make them an ideal manufacturing partner and align perfectly with our mission to deliver transformative therapies for cardiovascular diseases and beyond." About Cellipont: Cellipont Bioservices is a premier Contract...

West introduces Daikyo PLASCAP® RUV closures in a new nested format at Pharmapack

drug administration, announced the introduction of Daikyo PLASCAP® Ready-to-Use Validated (RUV) closures in a new nested format available in multiple configurations at this year's Pharmapack event in Paris, France. This marks West's latest product...

Artax Biopharma validates AX-158, a first-in-class oral Nck modulator, in phase 2a for autoimmune disease

Artax Biopharma, Inc., a clinical-stage biotechnology company focused on transforming the treatment of autoimmune diseases, today announces achievement of clinical validation through its Phase 2a clinical trial in psoriasis with fully proprietary...

MalarVx licenses HDT Bio's repRNA/LION™ technology to develop a groundbreaking malaria vaccine

technologies in an effort to develop malaria vaccines with MalarVx," said Steve Reed, Ph.D., CEO of HDT Bio. "Our LION platform has a demonstrated ability to rapidly generate potent, durable immune responses with a favorable safety profile." "This...

SeoulTech researchers unveil a novel approach to understanding PFOS-induced neurotoxicity, advancing environmental health studies

we elucidated the biomolecular mechanisms underlying PFOS-induced neurobehavioral changes and evaluated the analytical performance of the MTBE-based strategy by comparing it with previous findings of PFOS-induced metabolomic dysregulation." In...

Chromatin Bioscience's synthetic promoter enables EsoBiotec's ESO-T01 CAR-T therapy to progress to clinical trials

reach the clinical stage and utilises a synthetic promoter designed using Chromatin Bio's proprietary promoter design platform, chromatinLENS, exclusively for EsoBiotec as part of its innovative approach to immunotherapy. EsoBiotec's ESO-T01,...

Quantum-Si launches Platinum® Pro, the end-to-end solution for gaining deeper insights in proteomics

for sequencing and analyzing proteins in a simple, integrated workflow. Its design prioritizes accessibility, transforming complex protein sequencing into a seamless process for every lab, everywhere. Platinum Pro is Quantum-Si’s newest...